brainstem nerve


UCSF neuro-oncologist Nancy Ann Oberheim Bush, MD, PhD with patient

While various immunotherapies work through different mechanisms, they are all designed to enhance the immune system’s ability to recognize and target cancer cells. Pembrolizumab does so by binding and inhibiting PD-1, a protein that normally protects the body from attacking itself.

Patient Care, Research
UCSF neuro-oncologist Jessica Schulte, MD, PhD
This month, neuro-oncologist Jessica Schulte, MD, PhD joins the UCSF Brain Tumor Center team. Dr. Schulte specializes in treatment of adolescent and adult glioma and neurofibromatosis.
Campus News, Patient Care